REV-ERB Agonist Boosts Sorafenib Against Liver Cancer
In a groundbreaking advance in liver cancer treatment, researchers have identified the metabolic clock protein REV-ERB as a pivotal factor...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
In a groundbreaking advance in liver cancer treatment, researchers have identified the metabolic clock protein REV-ERB as a pivotal factor...
In the evolving landscape of oncology research, the intricate molecular mechanisms that drive the progression of ovarian cancer continue to...
As the landscape of precision cancer medicine continues to evolve, the integration of advanced data analytics and machine learning is...
A groundbreaking study has recently emerged, spotlighting the significant role that gut microbiota play in reshaping the immune microenvironment within...
A recent study has unveiled significant insights into the mechanisms by which the immune system identifies and disposes of dead...
In a significant advancement for cancer diagnostics, a team of researchers led by Ball, Beck, Wlochowitz, and their colleagues have...
In the light of groundbreaking research published in the field of hematology, scientists have unveiled critical insights into acute myeloid...
In a pioneering study that intersects the fields of radiology, genomics, and immunology, researchers have unveiled crucial insights into the...
In a groundbreaking study set to redefine our understanding of cancer metabolism and RNA modification, researchers have uncovered a novel...
Acute-on-chronic liver failure (ACLF) represents one of the most challenging scenarios in hepatology, characterized by rapid deterioration of liver function...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine